Drugs / Live Attenuated Flu Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04080245 | Nov 2019 → Jun 2025 | influenza | University of Alabama at Birmingham | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live Attenuated Flu Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04080245 ↗ |
| Known as | Flumist | “As yet the investigators do not understand if there are biomarkers of immune protection after the Flumist or Live Attenuated Flu Vaccine (LAIV).” NCT04080245 ↗ |
| Modality | Vaccine | “LAIV once as a vaccine prime” NCT04080245 ↗ |